Future Microbiol. 2008;3(6):649-660.

Bacteria detect cell wall fragments as danger signals and form protective biofilms, a survival strategy seen across species ...

Acinetobacter baumannii has emerged in the last decades as a major cause of healthcare-associated infections and nosocomial outbreaks. Multidrug-resistant (MDR) A. baumannii is a rapidly emerging ...

IIT-Bombay researchers identify bacteria Pseudomonas and Acinetobacter with potential in agriculture by breaking down harmful ...

MRX-8 is under clinical development by MicuRx Pharmaceuticals and currently in Phase I for Acinetobacter Infections. According to GlobalData, Phase I drugs for Acinetobacter Infections does not have ...

Testing new antibiotics in India, South Africa, or Brazil, where they are needed most, makes scientific sense. But it’s not ...

Shares of Wockhardt were in high demand on Monday after the company said that its drug Zaynich has achieved over 97 per cent ...

Achieved record fourth quarter and full-year 2024 sepsis product revenuesLEXINGTON, Mass., Jan. 07, 2025 (GLOBE NEWSWIRE) -- ...

A new experimental antibiotic Zaynich has shown 97% effectiveness in fighting drug-resistant infections, offering hope ...